Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.59 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.44.
Market Cap
9.59T
Revenue
4.66T
Profits
186.47B
PE Ratio
51.44
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.13T | -1.06% | 864,572 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 651.88B | -1.06% | 2,001,258 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.35B | -0.35% | 2,170,268 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 374.02B | -0.39% | 7,621,159 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 347.76B | -0.30% | 1,769,799 | 450.53B |
| 6 | NVS | Novartis AG | 300.60B | -1.82% | 655,720 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 254.32B | 0.11% | 3,006,117 | 61.37B |
| 8 | AMGN | Amgen Inc. | 235.28B | -1.62% | 925,127 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.96B | 2.69% | 1,270,214 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 204.73B | -0.10% | 4,385,402 | 50.34B |
| 11 | ABT | Abbott Laboratories | 197.78B | -0.11% | 1,960,696 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 180.60B | -1.32% | 1,881,422 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.93B | -0.64% | 14,966,077 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.03B | 2.92% | 2,960,393 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 137.95B | -1.41% | 259,011 | 12.59B |
| 16 | ISRG | Intuitive Surgical, Inc. | 136.34B | -2.96% | 1,197,780 | 11.03B |
| 17 | BMY | Bristol-Myers Squibb Company | 135.77B | -1.69% | 4,383,108 | 49.19B |
| 18 | SYK | Stryker Corporation | 129.48B | -0.71% | 523,992 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.29B | 0.43% | 1,855,838 | 412.65B |
| 20 | MDT | Medtronic plc | 119.13B | -1.13% | 1,877,189 | 36.36B |
| 21 | SNY | Sanofi | 108.85B | -1.27% | 1,318,891 | 55.89B |
| 22 | GSK | GSK plc | 104.47B | -1.13% | 2,263,902 | 44.05B |
| 23 | MCK | McKesson Corporation | 99.05B | -0.49% | 219,676 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.03B | -0.11% | 336,778 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.37B | -0.05% | 196,106 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 83.34B | -0.74% | 188,325 | 15.53B |
| 27 | CI | The Cigna Group | 72.99B | -0.45% | 335,112 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 72.58B | -3.71% | 9,704,261 | 21.00B |
| 29 | ARGX | argenx SE | 63.98B | 0.21% | 128,411 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.54B | 0.05% | 451,159 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.68B | -0.65% | 1,068,132 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 53.75B | -1.60% | 425,579 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 52.18B | -1.90% | 701,296 | 6.51B |
| 34 | MRNA | Moderna, Inc. | 51.71B | -25.73% | 64,733,148 | 2.23B |
| 35 | BDX | Becton, Dickinson and Company | 51.61B | 1.00% | 608,143 | 22.48B |
| 36 | NTRA | Natera, Inc. | 47.59B | 1.56% | 713,614 | 2.71B |
| 37 | HUM | Humana Inc. | 46.10B | 1.55% | 588,753 | 145.68B |
| 38 | RVMD | Revolution Medicines, Inc. | 44.97B | -2.25% | 568,199 | - |
| 39 | A | Agilent Technologies, Inc. | 44.57B | 1.55% | 1,273,823 | 7.23B |
| 40 | IDXX | IDEXX Laboratories, Inc. | 43.69B | -1.35% | 156,809 | 4.55B |
| 41 | MDLN | Medline Inc. | 43.41B | -2.62% | 2,223,493 | 29.94B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 43.35B | -0.72% | 1,520,994 | 17.32B |
| 43 | HLN | Haleon plc | 42.90B | 0.25% | 4,736,968 | 14.80B |
| 44 | IQV | IQVIA Holdings Inc. | 42.67B | 3.98% | 767,142 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.45B | -0.94% | 79,347 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 41.00B | 0.55% | 465,862 | 3.32B |
| 47 | WAT | Waters Corporation | 40.91B | 0.13% | 436,954 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.84B | -0.47% | 518,424 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.16B | -0.96% | 1,399,809 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.09B | 0.50% | 3,231,767 | 4.97B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 34.01B | 0.90% | 660,686 | 21.27B |
| 52 | RMD | ResMed Inc. | 33.41B | 0.40% | 336,989 | 5.65B |
| 53 | ILMN | Illumina, Inc. | 32.59B | 5.30% | 1,715,280 | 4.49B |
| 54 | BIIB | Biogen Inc. | 32.21B | -1.60% | 213,681 | 10.03B |
| 55 | CNC | Centene Corporation | 31.85B | -0.34% | 1,576,812 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 31.42B | -0.83% | 1,532,462 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.36B | -3.38% | 779,627 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.59B | 0.13% | 166,573 | 4.13B |
| 59 | BNTX | BioNTech SE | 27.83B | -2.05% | 2,439,866 | 3.03B |
| 60 | INSM | Insmed Incorporated | 27.59B | -3.32% | 640,675 | 1.14B |
| 61 | LH | Labcorp Holdings Inc. | 27.38B | 2.18% | 238,902 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.90B | 0.81% | 401,080 | 11.56B |
| 63 | PHG | Koninklijke Philips N.V. | 26.88B | 0.11% | 216,664 | 20.18B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.68B | -1.23% | 1,058,720 | 7.53M |
| 65 | INCY | Incyte Corporation | 26.03B | -0.02% | 397,605 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 25.12B | 1.16% | 204,759 | 3.33B |
| 67 | STE | STERIS plc | 23.16B | 0.27% | 195,353 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.77B | 3.88% | 1,015,672 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.40B | -1.32% | 113,589 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 22.08B | 2.14% | 196,926 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.98B | -1.99% | 2,795,594 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.21B | -0.03% | 292,849 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.48B | -0.95% | 1,741,416 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.35B | 2.16% | 117,570 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 17.00B | -0.32% | 248,501 | 1.20B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.26B | -0.94% | 948,823 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.04B | -2.03% | 136,409 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.67B | -0.88% | 259,066 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.22B | 1.80% | 247,603 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 15.01B | 0.28% | 365,369 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.10B | 1.87% | 432,500 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.84B | 3.81% | 714,541 | 2.91B |
| 83 | ICLR | ICON Public Limited Company | 13.75B | 3.35% | 160,761 | 8.29B |
| 84 | BAX | Baxter International Inc. | 13.64B | -0.98% | 1,117,004 | 11.47B |
| 85 | EXEL | Exelixis, Inc. | 13.41B | -0.48% | 633,682 | 2.44B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 13.22B | -1.47% | 383,045 | 3.41B |
| 87 | CORT | Corcept Therapeutics Incorporated | 13.15B | 2.20% | 260,172 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.81B | -0.48% | 45,089 | 1.50B |
| 89 | FMS | Fresenius Medical Care AG | 12.65B | -1.17% | 441,461 | 22.19B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.52B | 1.26% | 705,965 | 14.37B |
| 91 | TEM | Tempus AI, Inc. | 12.23B | 10.69% | 14,747,423 | 1.43B |
| 92 | SNN | Smith & Nephew plc | 12.23B | -0.10% | 520,847 | 6.30B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.22B | -2.09% | 102,418 | 1.28B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.20B | -3.38% | 363,590 | 669.50M |
| 95 | HALO | Halozyme Therapeutics, Inc. | 12.10B | -0.92% | 541,233 | 1.66B |
| 96 | EHC | Encompass Health Corporation | 12.02B | 0.12% | 283,333 | 6.21B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.79B | -3.67% | 1,402,658 | 5.02B |
| 98 | GMED | Globus Medical, Inc. | 11.68B | -1.52% | 266,795 | 3.14B |
| 99 | ALGN | Align Technology, Inc. | 11.29B | -2.53% | 307,376 | 4.14B |
| 100 | TECH | Bio-Techne Corporation | 11.28B | -0.11% | 1,852,755 | 1.22B |
| 101 | DVA | DaVita Inc. | 11.22B | -0.72% | 149,344 | 14.01B |
| 102 | GKOS | Glaukos Corporation | 11.13B | -0.39% | 255,208 | 612.84M |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.96B | -4.07% | 193,004 | 776.57M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.65B | -1.44% | 715,369 | 67.67M |
| 105 | ENSG | The Ensign Group, Inc. | 10.43B | -1.12% | 150,420 | 5.49B |
| 106 | MOH | Molina Healthcare, Inc. | 10.42B | -0.56% | 158,794 | 42.47B |
| 107 | PODD | Insulet Corporation | 10.39B | -1.08% | 400,129 | 3.05B |
| 108 | ABVX | ABIVAX Société Anonyme | 10.38B | -2.46% | 571,790 | 5.67M |
| 109 | RGEN | Repligen Corporation | 10.38B | 4.27% | 886,235 | 785.10M |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.30B | 0.54% | 1,402,103 | 3.50B |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.24B | -5.04% | 198,119 | 7.46M |
| 112 | UHS | Universal Health Services, Inc. | 10.24B | 0.81% | 164,746 | 18.11B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 10.24B | -3.31% | 205,335 | 105.00M |
| 114 | OSCR | Oscar Health, Inc. | 10.21B | 2.57% | 3,523,395 | 15.32B |
| 115 | APGE | Apogee Therapeutics, Inc. | 10.16B | 0.04% | 778,168 | - |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 10.06B | 3.31% | 69,752 | 2.59B |
| 117 | KRYS | Krystal Biotech, Inc. | 10.01B | -1.49% | 57,648 | 440.48M |
| 118 | SMMT | Summit Therapeutics Inc. | 9.89B | -5.42% | 2,692,558 | - |
| 119 | HSIC | Henry Schein, Inc. | 9.89B | -0.61% | 195,806 | 13.60B |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.87B | -2.29% | 700,160 | 874.09M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.73B | -2.96% | 160,019 | 281.99M |
| 122 | AVTR | Avantor, Inc. | 9.71B | 2.79% | 3,774,928 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.35B | -2.61% | 259,945 | - |
| 124 | QGEN | Qiagen N.V. | 9.29B | 0.92% | 1,834,444 | 2.10B |
| 125 | BRKR | Bruker Corporation | 9.24B | 3.43% | 696,349 | 3.50B |
| 126 | PCVX | Vaxcyte, Inc. | 9.18B | -2.54% | 272,743 | - |
| 127 | IMVT | Immunovant, Inc. | 9.09B | -2.16% | 316,405 | - |
| 128 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.02% | 1,926,368 | 42.16M |
| 129 | TWST | Twist Bioscience Corporation | 8.86B | -0.80% | 1,308,601 | 431.80M |
| 130 | HQY | HealthEquity, Inc. | 8.82B | 1.47% | 287,299 | 1.34B |
| 131 | ATR | AptarGroup, Inc. | 8.46B | 0.12% | 151,427 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.29B | 2.36% | 1,691,450 | 616.91M |
| 133 | IBRX | ImmunityBio, Inc. | 8.27B | -4.00% | 4,103,423 | 165.79M |
| 134 | ALKS | Alkermes plc | 8.18B | -2.79% | 358,690 | 1.67B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.60B | -4.63% | 228,748 | 239.92M |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.56B | 4.28% | 12,897,763 | 2.58B |
| 137 | TGTX | TG Therapeutics, Inc. | 7.23B | -1.45% | 1,382,894 | 799.54M |
| 138 | GRFS | Grifols, S.A. | 7.11B | -1.70% | 126,867 | 8.48B |
| 139 | HNGE | Hinge Health, Inc. | 7.06B | -1.12% | 766,014 | 720.06M |
| 140 | CHE | Chemed Corporation | 7.01B | 0.55% | 51,207 | 2.60B |
| 141 | PACS | PACS Group, Inc. | 7.00B | -0.11% | 247,231 | 5.55B |
| 142 | CGON | CG Oncology, Inc. | 6.97B | -2.59% | 298,100 | 6.23M |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.96B | -4.11% | 206,622 | - |
| 144 | CAI | Caris Life Sciences, Inc. | 6.92B | 7.60% | 3,015,318 | 989.61M |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.72B | -2.41% | 407,509 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.30% | 658,942 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.54B | -3.71% | 57,585 | - |
| 148 | LQDA | Liquidia Corporation | 6.43B | -4.65% | 636,744 | 450.91M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.36B | -4.15% | 117,270 | 618.07M |
| 150 | BLCO | Bausch + Lomb Corporation | 6.21B | -0.37% | 117,170 | 5.32B |
| 151 | COGT | Cogent Biosciences, Inc. | 6.12B | -4.31% | 833,779 | - |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.12B | -2.95% | 140,613 | 840.85M |
| 153 | TVTX | Travere Therapeutics, Inc. | 6.09B | -2.09% | 339,201 | 591.33M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.08B | -4.41% | 261,409 | 1.90M |
| 155 | RDNT | RadNet, Inc. | 6.06B | 2.01% | 125,401 | 2.27B |
| 156 | STVN | Stevanato Group S.p.A. | 6.04B | 1.80% | 130,759 | 1.40B |
| 157 | DFTX | Definium Therapeutics, Inc. | 6.02B | -2.29% | 686,763 | - |
| 158 | ERAS | Erasca, Inc. | 5.98B | -5.42% | 1,057,671 | - |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.95B | -3.15% | 317,877 | 1.01B |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.84B | -3.29% | 198,488 | 7.50M |
| 161 | TFX | Teleflex Incorporated | 5.80B | 0.79% | 79,294 | 2.25B |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.73B | -0.88% | 284,347 | 3.12B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | -1.31% | 51,001 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.69B | -1.54% | 1,793,789 | 13.39M |
| 165 | MMED | MiniMed Group, Inc. | 5.65B | -0.54% | 556,314 | 3.10B |
| 166 | SHC | Sotera Health Company | 5.48B | 1.16% | 1,029,386 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.42B | -1.28% | 331,852 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.05B | -2.91% | 360,153 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.97B | 0.66% | 225,033 | 1.35B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.93B | -3.44% | 102,375 | 148.00K |
| 171 | LFST | LifeStance Health Group, Inc. | 4.87B | -0.62% | 716,461 | 1.58B |
| 172 | DYN | Dyne Therapeutics, Inc. | 4.84B | -3.14% | 622,244 | - |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -5.21% | 318,128 | - |
| 174 | WAY | Waystar Holding Corp. | 4.76B | -0.12% | 331,830 | 1.21B |
| 175 | ICUI | ICU Medical, Inc. | 4.68B | -0.14% | 99,382 | 2.16B |
| 176 | DOCS | Doximity, Inc. | 4.67B | 1.71% | 927,119 | 655.57M |
| 177 | INDV | Indivior Pharmaceuticals, Inc. | 4.53B | -1.64% | 328,615 | 1.33B |
| 178 | BLLN | BillionToOne, Inc. | 4.51B | 4.35% | 248,372 | 397.41M |
| 179 | CELC | Celcuity Inc. | 4.48B | -2.33% | 207,871 | - |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.47B | 0.89% | 126,485 | 2.29B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.41B | 2.59% | 4,815,922 | -665.00K |
| 182 | NVST | Envista Holdings Corporation | 4.38B | -1.05% | 502,997 | 2.86B |
| 183 | LIVN | LivaNova PLC | 4.33B | -2.76% | 141,858 | 1.47B |
| 184 | MANE | Veradermics, Incorporated | 4.32B | -7.06% | 363,740 | - |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.31B | -5.21% | 1,160,538 | 10.35M |
| 186 | ITGR | Integer Holdings Corporation | 4.26B | 0.02% | 248,768 | 1.84B |
| 187 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -2.63% | 236,661 | - |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.22B | 2.69% | 190,878 | 825.34M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.20B | 1.49% | 180,284 | 890.79M |
| 190 | LEGN | Legend Biotech Corporation | 4.15B | -5.09% | 1,254,437 | 1.27B |
| 191 | HTFL | HeartFlow, Inc. | 4.14B | 4.50% | 832,170 | 212.07M |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 4.09B | 0.43% | 652,747 | 308.08M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.99B | -4.84% | 873,205 | - |
| 194 | DNLI | Denali Therapeutics Inc. | 3.98B | -3.19% | 333,573 | 3.60M |
| 195 | TNGX | Tango Therapeutics, Inc. | 3.95B | -7.10% | 686,005 | 53.81M |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | 8.76% | 20,073,190 | 324.97M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.81B | -1.32% | 1,014,618 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.76B | -3.50% | 3,606,027 | 66.17M |
| 199 | NHC | National HealthCare Corporation | 3.74B | 1.91% | 35,942 | 1.56B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.70B | -4.12% | 471,804 | - |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.70B | -1.44% | 254,960 | 234.13M |
| 202 | OGN | Organon & Co. | 3.61B | 0.04% | 2,056,748 | 6.13B |
| 203 | GRAL | GRAIL, Inc. | 3.55B | 7.50% | 797,590 | 165.26M |
| 204 | OPCH | Option Care Health, Inc. | 3.51B | 0.47% | 414,844 | 5.69B |
| 205 | WRBY | Warby Parker Inc. | 3.41B | -3.26% | 925,853 | 911.61M |
| 206 | PLSE | Pulse Biosciences, Inc. | 3.41B | 1.60% | 93,083 | 1.19M |
| 207 | QURE | uniQure N.V. | 3.38B | 0.04% | 499,106 | 18.67M |
| 208 | VCYT | Veracyte, Inc. | 3.38B | -0.36% | 370,121 | 561.90M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.31B | -2.87% | 260,637 | 7.12M |
| 210 | IMNM | Immunome, Inc. | 3.23B | -4.64% | 344,183 | 4.02M |
| 211 | TMDX | TransMedics Group, Inc. | 3.22B | -1.03% | 175,422 | 668.47M |
| 212 | MBX | MBX Biosciences, Inc. | 3.19B | -3.01% | 131,359 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -4.95% | 1,618,465 | 463.98M |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.14B | -4.22% | 566,078 | 158.00K |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | -3.50% | 165,560 | 606.33M |
| 216 | IRON | Disc Medicine, Inc. | 3.04B | -1.27% | 107,463 | - |
| 217 | ZLAB | Zai Lab Limited | 2.93B | -2.28% | 591,707 | 449.61M |
| 218 | BKD | Brookdale Senior Living Inc. | 2.91B | 0.58% | 958,646 | 2.93B |
| 219 | AVAH | Aveanna Healthcare Holdings Inc. | 2.89B | 0.76% | 1,047,792 | 2.60B |
| 220 | ALMS | Alumis Inc. | 2.88B | -7.25% | 453,165 | 7.40M |
| 221 | SLS | SELLAS Life Sciences Group, Inc. | 2.83B | 1.01% | 4,106,473 | - |
| 222 | BEAM | Beam Therapeutics Inc. | 2.81B | -3.25% | 1,503,857 | 156.04M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -3.17% | 425,098 | 36.77M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | -1.71% | 203,167 | 830.44M |
| 225 | RGC | Regencell Bioscience Holdings Limited | 2.75B | -4.48% | 98,850 | - |
| 226 | ATAI | AtaiBeckley Inc. | 2.75B | 0.68% | 3,677,683 | 4.47M |
| 227 | VRDN | Viridian Therapeutics, Inc. | 2.73B | -2.82% | 275,419 | 71.13M |
| 228 | PRVA | Privia Health Group, Inc. | 2.72B | -1.07% | 196,422 | 2.36B |
| 229 | ALHC | Alignment Healthcare, Inc. | 2.70B | 1.92% | 1,372,001 | 4.58B |
| 230 | TRVI | Trevi Therapeutics, Inc. | 2.62B | -2.18% | 582,509 | - |
| 231 | NEOG | Neogen Corporation | 2.61B | -1.56% | 424,562 | 870.40M |
| 232 | BHC | Bausch Health Companies Inc. | 2.58B | - | 1,090,866 | 10.85B |
| 233 | PGEN | Precigen, Inc. | 2.57B | 0.14% | 1,805,484 | 85.72M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | -1.41% | 2,152,960 | 717.00M |
| 235 | ACHC | Acadia Healthcare Company, Inc. | 2.54B | -0.48% | 353,379 | 3.37B |
| 236 | NKTR | Nektar Therapeutics | 2.53B | -2.79% | 198,636 | 54.59M |
| 237 | PHVS | Pharvaris N.V. | 2.52B | -0.94% | 226,841 | - |
| 238 | KOD | Kodiak Sciences Inc. | 2.49B | -1.12% | 193,595 | - |
| 239 | BFLY | Butterfly Network, Inc. | 2.48B | 1.64% | 1,539,011 | 112.14M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | -3.87% | 953,684 | 940.61M |
| 241 | WGS | GeneDx Holdings Corp. | 2.47B | 3.78% | 174,381 | 454.43M |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.46B | -4.35% | 968,621 | 52.06M |
| 243 | CDNA | CareDx, Inc. | 2.45B | 1.74% | 348,197 | 458.09M |
| 244 | AXGN | Axogen, Inc. | 2.44B | -7.07% | 387,395 | 251.17M |
| 245 | ATRC | AtriCure, Inc. | 2.42B | -0.04% | 506,221 | 569.62M |
| 246 | NUVB | Nuvation Bio Inc. | 2.42B | -5.23% | 2,728,840 | 169.90M |
| 247 | UFPT | UFP Technologies, Inc. | 2.41B | -0.34% | 50,038 | 631.64M |
| 248 | PBH | Prestige Consumer Healthcare Inc. | 2.41B | -1.55% | 92,726 | 1.10B |
| 249 | ALMR | Alamar Biosciences, Inc. | 2.39B | -3.11% | 109,313 | 100.42M |
| 250 | GRDN | Guardian Pharmacy Services, Inc. | 2.39B | -0.83% | 46,288 | 1.46B |
| 251 | MESO | Mesoblast Limited | 2.32B | 2.98% | 194,016 | 65.38M |
| 252 | AUPH | Aurinia Pharmaceuticals Inc. | 2.28B | 6.00% | 1,528,253 | 311.51M |
| 253 | KLRA | Kailera Therapeutics, Inc. | 2.28B | -4.04% | 292,134 | - |
| 254 | URGN | UroGen Pharma Ltd. | 2.28B | -7.36% | 438,183 | 188.73M |
| 255 | RAPP | Rapport Therapeutics, Inc. | 2.28B | -3.34% | 70,246 | 20.00M |
| 256 | VERA | Vera Therapeutics, Inc. | 2.27B | -2.51% | 476,928 | - |
| 257 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -4.94% | 310,808 | - |
| 258 | NBTX | Nanobiotix S.A. | 2.25B | -5.02% | 103,236 | 38.27M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -3.63% | 172,418 | 959.90M |
| 260 | CLOV | Clover Health Investments, Corp. | 2.22B | -0.95% | 1,627,376 | 2.48B |
| 261 | ADUS | Addus HomeCare Corporation | 2.21B | 0.61% | 53,426 | 1.48B |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.20B | -8.85% | 175,060 | - |
| 263 | ADMA | ADMA Biologics, Inc. | 2.19B | -2.54% | 582,599 | 512.28M |
| 264 | VCEL | Vericel Corporation | 2.16B | -3.00% | 171,651 | 306.30M |
| 265 | XRAY | DENTSPLY SIRONA Inc. | 2.16B | -1.63% | 1,194,350 | 3.64B |
| 266 | HCM | HUTCHMED (China) Limited | 2.16B | -0.71% | 11,415 | 549.12M |
| 267 | ESTA | Establishment Labs Holdings Inc. | 2.14B | -4.72% | 168,424 | 245.82M |
| 268 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.13B | 13.50% | 8,036,119 | 208.78M |
| 269 | NEO | NeoGenomics, Inc. | 2.13B | -0.57% | 1,349,224 | 766.30M |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.08B | 0.23% | 343,438 | 1.95B |
| 271 | GENB | Generate Biomedicines, Inc. | 2.08B | -4.71% | 427,896 | 26.48M |
| 272 | NVCR | NovoCure Limited | 2.05B | -3.13% | 336,314 | 699.19M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -2.73% | 232,084 | 98.34M |
| 274 | PVLA | Palvella Therapeutics, Inc. | 2.04B | -5.67% | 44,447 | - |
| 275 | XNCR | Xencor, Inc. | 2.04B | -0.44% | 413,928 | 104.97M |
| 276 | BHVN | Biohaven Ltd. | 2.03B | -4.95% | 2,397,722 | - |
| 277 | ASTH | Astrana Health, Inc. | 2.01B | -0.41% | 59,119 | 3.84B |
| 278 | PGNY | Progyny, Inc. | 2.00B | 2.23% | 426,343 | 1.31B |
| 279 | ZBIO | Zenas BioPharma, Inc. | 2.00B | -1.73% | 404,615 | 1.00M |
| 280 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -4.05% | 873,453 | 1.97B |
| 281 | GHRS | GH Research PLC | 1.97B | -3.76% | 68,197 | - |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.96B | -8.11% | 252,974 | 27.59M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | -6.69% | 662,458 | 5.49M |
| 284 | LKFT | Lakefront Biotherapeutics NV | 1.95B | -3.24% | 154,505 | 1.13B |
| 285 | TRLV | Trulieve Cannabis Corp. | 1.95B | 0.25% | 555,559 | 1.14B |
| 286 | SEPN | Septerna, Inc. | 1.94B | -5.51% | 118,235 | 98.88M |
| 287 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 2,622,142 | - |
| 288 | KARD | Kardigan, Inc. | 1.92B | -6.57% | 107,182 | - |
| 289 | CMPS | COMPASS Pathways plc | 1.92B | -1.21% | 1,249,457 | - |
| 290 | PRGO | Perrigo Company plc | 1.92B | -1.07% | 746,585 | 4.14B |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.90B | -1.13% | 66,407 | 481.07M |
| 292 | LMAT | LeMaitre Vascular, Inc. | 1.89B | -1.35% | 84,359 | 262.43M |
| 293 | DMRA | Damora Therapeutics, Inc. | 1.89B | -5.58% | 70,324 | - |
| 294 | ZYME | Zymeworks Inc. | 1.88B | -2.79% | 117,840 | 37.13M |
| 295 | IMCR | Immunocore Holdings plc | 1.85B | -2.69% | 140,596 | 430.78M |
| 296 | BLFS | BioLife Solutions, Inc. | 1.84B | 3.13% | 255,484 | 106.69M |
| 297 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | -4.14% | 14,655,628 | 54.86M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | -3.56% | 285,310 | 252.25M |
| 299 | PSNL | Personalis, Inc. | 1.79B | 5.82% | 10,753,970 | 69.67M |
| 300 | SGRY | Surgery Partners, Inc. | 1.78B | 0.96% | 1,815,698 | 3.37B |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -4.44% | 2,285,286 | 59.51M |
| 302 | INSP | Inspire Medical Systems, Inc. | 1.77B | -0.53% | 139,606 | 898.74M |
| 303 | BRVE | Braveheart Bio, Inc. | 1.76B | -5.07% | 103,994 | - |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.75B | -0.18% | 218,456 | 105.60M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.74B | 0.88% | 410,286 | 2.68B |
| 306 | ANAB | AnaptysBio, Inc. | 1.68B | -4.02% | 147,846 | 232.39M |
| 307 | AVLN | Avalyn Pharma Inc. | 1.67B | -3.49% | 57,803 | - |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.41% | 59,140 | 978.38M |
| 309 | ABSI | Absci Corporation | 1.65B | -3.90% | 1,441,533 | 1.56M |
| 310 | OMCL | Omnicell, Inc. | 1.64B | -1.15% | 183,273 | 1.25B |
| 311 | AGL | agilon health, inc. | 1.64B | 4.39% | 78,825 | 5.92B |
| 312 | SLBT | SL Science Holding Limited | 1.64B | 7.49% | 54,991 | 3.27M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.63B | -4.91% | 166,914 | - |
| 314 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -0.63% | 104,324 | 95.13M |
| 315 | AZTA | Azenta, Inc. | 1.62B | 3.82% | 212,679 | 613.81M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.60B | -3.39% | 93,412 | 20.00M |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.60B | -0.28% | 666,575 | 335.41M |
| 318 | TNDM | Tandem Diabetes Care, Inc. | 1.59B | -2.81% | 476,783 | 1.04B |
| 319 | HROW | Harrow, Inc. | 1.58B | 1.34% | 176,989 | 275.59M |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.58B | 0.22% | 286,796 | 1.86B |
| 321 | AAPG | Ascentage Pharma Group International | 1.58B | -6.82% | 10,171 | 94.61M |
| 322 | CNMD | CONMED Corporation | 1.56B | 1.65% | 75,377 | 1.37B |
| 323 | TRAX | First Tracks Biotherapeutics, Inc. | 1.56B | -4.15% | 167,243 | - |
| 324 | VIR | Vir Biotechnology, Inc. | 1.55B | -6.35% | 302,776 | 303.23M |
| 325 | LBRX | LB Pharmaceuticals Inc | 1.53B | -2.79% | 47,870 | - |
| 326 | ENOV | Enovis Corporation | 1.53B | 0.36% | 164,792 | 2.30B |
| 327 | FRNM | Freenome, Inc. | 1.53B | -0.37% | 334,983 | 34.24M |
| 328 | INVA | Innoviva, Inc. | 1.53B | -1.40% | 209,407 | 440.00M |
| 329 | TYRA | Tyra Biosciences, Inc. | 1.51B | -5.39% | 81,414 | - |
| 330 | ALVO | Alvotech | 1.50B | 5.01% | 909,261 | 494.61M |
| 331 | OMDA | Omada Health, Inc. | 1.49B | -0.35% | 239,311 | 309.76M |
| 332 | ARDT | Ardent Health, Inc. | 1.48B | -1.32% | 69,320 | 6.41B |
| 333 | SDGR | Schrödinger, Inc. | 1.47B | -0.86% | 388,474 | 259.04M |
| 334 | INNV | InnovAge Holding Corp. | 1.46B | -1.46% | 33,448 | 949.17M |
| 335 | INBX | Inhibrx Biosciences, Inc. | 1.46B | -2.17% | 131,894 | 1.30M |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.45B | -4.54% | 282,755 | - |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.44B | -4.10% | 359,983 | 815.05M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.44B | 0.37% | 66,319 | 1.50B |
| 339 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -3.30% | 205,876 | - |
| 340 | MGTX | MeiraGTx Holdings plc | 1.43B | -0.67% | 236,684 | 397.50M |
| 341 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | -4.09% | 272,352 | - |
| 342 | AORT | Artivion, Inc. | 1.38B | -1.68% | 104,355 | 471.47M |
| 343 | PNTG | The Pennant Group, Inc. | 1.37B | 0.20% | 33,689 | 1.10B |
| 344 | VOR | Vor Biopharma Inc. | 1.37B | -1.93% | 268,104 | - |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.36B | -0.25% | 92,406 | 3.43B |
| 346 | NVAX | Novavax, Inc. | 1.36B | -6.31% | 3,600,108 | 413.80M |
| 347 | REPL | Replimune Group, Inc. | 1.35B | -3.11% | 1,926,761 | - |
| 348 | SVRA | Savara Inc. | 1.35B | -4.84% | 894,189 | - |
| 349 | CERT | Certara, Inc. | 1.34B | 5.44% | 864,874 | 421.75M |
| 350 | MNKD | MannKind Corporation | 1.34B | -4.89% | 1,722,103 | 393.63M |
| 351 | LTGO | Latigo Biotherapeutics, Inc. | 1.34B | 1.24% | 44,275 | - |
| 352 | MLTX | MoonLake Immunotherapeutics | 1.34B | -6.09% | 472,651 | - |
| 353 | JBIO | Jade Biosciences, Inc. | 1.34B | -6.78% | 266,699 | - |
| 354 | ANRO | Alto Neuroscience, Inc. | 1.34B | -2.41% | 153,800 | - |
| 355 | OMER | Omeros Corporation | 1.34B | 0.33% | 667,793 | 38.42M |
| 356 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.41% | 173,503 | - |
| 357 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -1.16% | 135,979 | 1.65B |
| 358 | AKTS | Aktis Oncology, Inc. | 1.32B | -5.08% | 112,878 | 10.06M |
| 359 | NUTX | Nutex Health Inc. | 1.30B | -0.65% | 42,450 | 846.72M |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -1.68% | 24,272 | - |
| 361 | GLUE | Monte Rosa Therapeutics, Inc. | 1.28B | -4.72% | 365,551 | 28.73M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.23B | -1.73% | 402,662 | 337.34M |
| 363 | APMD | Apnimed, Inc. | 1.21B | -5.25% | 289,673 | 120.15M |
| 364 | CRON | Cronos Group Inc. | 1.21B | -1.98% | 541,784 | 179.09M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | -7.14% | 219,728 | - |
| 366 | BVS | Bioventus Inc. | 1.20B | -2.59% | 196,007 | 581.85M |
| 367 | GDRX | GoodRx Holdings, Inc. | 1.20B | -0.85% | 1,068,441 | 785.23M |
| 368 | TDOC | Teladoc Health, Inc. | 1.19B | -1.73% | 992,722 | 2.49B |
| 369 | IMTX | Immatics N.V. | 1.19B | -6.05% | 277,150 | 47.65M |
| 370 | STAA | STAAR Surgical Company | 1.18B | -4.28% | 266,509 | 339.59M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.18B | - | 55,918 | 804.27M |
| 372 | SANA | Sana Biotechnology, Inc. | 1.14B | -6.95% | 1,376,154 | - |
| 373 | ODTX | Odyssey Therapeutics, Inc. | 1.14B | -2.10% | 56,370 | 99.00K |
| 374 | IRMD | IRADIMED CORPORATION | 1.12B | 0.56% | 37,425 | 86.34M |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -1.69% | 794,926 | 1.04B |
| 376 | GMRS | GMR Solutions Inc. | 1.11B | -0.62% | 377,903 | 5.88B |
| 377 | OPK | OPKO Health, Inc. | 1.09B | 0.34% | 1,178,217 | 587.90M |
| 378 | IVA | Inventiva S.A. | 1.09B | -2.31% | 229,883 | 7.94M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.06B | -4.63% | 225,839 | 59.00K |
| 380 | JANX | Janux Therapeutics, Inc. | 1.06B | -1.03% | 322,303 | 24.00M |
| 381 | KURA | Kura Oncology, Inc. | 1.05B | -5.43% | 1,059,960 | 77.23M |
| 382 | WVE | Wave Life Sciences, Inc. | 1.03B | -3.23% | 1,008,886 | 65.37M |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -4.56% | 1,266,427 | 41.47M |
| 384 | CSTL | Castle Biosciences, Inc. | 1.01B | 2.75% | 131,090 | 357.28M |
| 385 | GERN | Geron Corporation | 1.01B | -0.69% | 2,233,839 | 204.56M |
| 386 | QDEL | QuidelOrtho Corporation | 1.01B | 7.10% | 778,439 | 2.67B |
| 387 | CLYM | Climb Bio, Inc. | 986.47M | -0.95% | 303,023 | - |
| 388 | ANNX | Annexon, Inc. | 981.07M | -5.91% | 603,616 | - |
| 389 | DSGN | Design Therapeutics, Inc. | 978.15M | -1.94% | 193,433 | - |
| 390 | SLDB | Solid Biosciences Inc. | 976.82M | -6.47% | 372,112 | - |
| 391 | ARDX | Ardelyx, Inc. | 970.59M | -3.35% | 1,827,487 | 450.89M |
| 392 | CADL | Candel Therapeutics, Inc. | 962.60M | -6.81% | 768,979 | - |
| 393 | PCRX | Pacira BioSciences, Inc. | 957.08M | -1.44% | 105,339 | 746.16M |
| 394 | ABUS | Arbutus Biopharma Corporation | 945.71M | -4.02% | 538,932 | 181.72M |
| 395 | OLMA | Olema Pharmaceuticals, Inc. | 940.60M | -4.95% | 518,587 | - |
| 396 | CBLL | CeriBell, Inc. | 939.50M | -1.65% | 62,966 | 101.96M |
| 397 | ATTO | Attovia Therapeutics, Inc. | 932.44M | -2.12% | 121,718 | 1.35M |
| 398 | IMMX | Immix Biopharma, Inc. | 932.16M | -1.21% | 751,018 | - |
| 399 | FDMT | 4D Molecular Therapeutics, Inc. | 918.71M | -0.78% | 524,874 | 92.01M |
| 400 | ACRS | Aclaris Therapeutics, Inc. | 917.05M | -3.26% | 559,360 | 8.22M |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 912.86M | -1.29% | 103,518 | 730.02M |
| 402 | AVR | Anteris Technologies Global Corp. | 909.29M | -5.09% | 404,498 | 2.24M |
| 403 | AHG | Akso Health Group | 908.11M | 9.65% | 11,608 | 13.83M |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 900.65M | -3.74% | 185,816 | 808.21M |
| 405 | ANL | Adlai Nortye Ltd. | 893.20M | -3.21% | 38,382 | 18.06M |
| 406 | OBX | Obsidian Therapeutics, Inc. | 892.09M | 2.95% | 34,215 | - |
| 407 | SGP | SpyGlass Pharma, Inc. | 882.86M | -3.07% | 20,244 | - |
| 408 | TBPH | Theravance Biopharma, Inc. | 880.80M | -0.15% | 72,649 | 104.31M |
| 409 | DBVT | DBV Technologies S.A. | 877.60M | -2.44% | 72,845 | 5.04M |
| 410 | SIBN | SI-BONE, Inc. | 868.14M | -2.71% | 112,227 | 213.60M |
| 411 | BBNX | Beta Bionics, Inc. | 861.55M | -4.30% | 1,070,911 | 119.01M |
| 412 | INMD | InMode Ltd. | 858.19M | -0.73% | 120,676 | 374.63M |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 851.99M | -2.87% | 88,427 | 276.79M |
| 414 | ACHV | Achieve Life Sciences, Inc. | 846.37M | -3.58% | 645,661 | - |
| 415 | HSTM | HealthStream, Inc. | 845.03M | 1.23% | 61,477 | 321.12M |
| 416 | GLAS | Glass House Brands Inc. | 844.81M | -2.89% | 70,377 | 177.68M |
| 417 | PHAR | Pharming Group N.V. | 832.13M | -0.30% | 11,420 | 366.48M |
| 418 | FTH | Faeth Therapeutics, Inc. | 821.21M | -4.02% | 161,775 | - |
| 419 | DRUG | Bright Minds Biosciences Inc. | 814.40M | -6.25% | 58,405 | - |
| 420 | OCS | Oculis Holding AG | 811.73M | -3.10% | 37,182 | 1.45M |
| 421 | SLN | Silence Therapeutics plc | 798.38M | -2.57% | 176,758 | 615.00K |
| 422 | MNPR | Monopar Therapeutics Inc. | 794.99M | -4.36% | 111,662 | - |
| 423 | AURA | Aura Biosciences, Inc. | 780.90M | -3.34% | 179,030 | - |
| 424 | VREX | Varex Imaging Corporation | 778.05M | - | 347,553 | 865.00M |
| 425 | HELP | Cybin Inc. | 767.36M | 5.09% | 816,712 | - |
| 426 | RGNX | REGENXBIO Inc. | 753.20M | -5.08% | 382,099 | 174.48M |
| 427 | NVCT | Nuvectis Pharma, Inc. | 751.98M | -1.07% | 107,878 | - |
| 428 | NGNE | Neurogene Inc. | 749.03M | -5.07% | 52,002 | 925.00K |
| 429 | PHR | Phreesia, Inc. | 745.45M | 0.84% | 312,524 | 495.59M |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 742.41M | -3.54% | 91,021 | - |
| 431 | GYRE | Gyre Therapeutics, Inc. | 740.12M | -2.38% | 30,462 | 109.82M |
| 432 | STTK | Shattuck Labs, Inc. | 738.67M | -3.92% | 95,058 | 1.00M |
| 433 | AHCO | AdaptHealth Corp. | 735.08M | -2.65% | 782,138 | 3.36B |
| 434 | ALLO | Allogene Therapeutics, Inc. | 728.99M | -5.38% | 2,632,049 | 4.64M |
| 435 | CTMX | CytomX Therapeutics, Inc. | 728.87M | -6.30% | 879,617 | 18.30M |
| 436 | TECX | Tectonic Therapeutic, Inc. | 720.49M | -0.50% | 57,836 | - |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 717.36M | -0.41% | 432,597 | 136.07M |
| 438 | SSII | SS Innovations International, Inc. | 712.37M | -1.25% | 35,033 | 52.40M |
| 439 | SOPH | SOPHiA GENETICS SA | 706.99M | 0.30% | 318,699 | 86.17M |
| 440 | EVO | Evotec SE | 705.36M | -3.03% | 15,419 | 819.47M |
| 441 | CBIO | Crescent Biopharma, Inc. | 695.52M | -6.18% | 27,807 | 11.88M |
| 442 | KIDS | OrthoPediatrics Corp. | 685.38M | -0.94% | 63,770 | 252.72M |
| 443 | IRWD | Ironwood Pharmaceuticals, Inc. | 683.27M | -5.16% | 543,499 | 389.32M |
| 444 | PHAT | Phathom Pharmaceuticals, Inc. | 682.30M | -7.83% | 538,659 | 239.66M |
| 445 | PRLD | Prelude Therapeutics Incorporated | 680.28M | 14.27% | 708,049 | 22.42M |
| 446 | SCTX | Scribe Therapeutics Inc. | 678.55M | 15.85% | 283,262 | 36.28M |
| 447 | ASMB | Assembly Biosciences, Inc. | 677.09M | -1.73% | 113,562 | 74.85M |
| 448 | STLN | Starling Oncology, Inc. | 670.61M | -1.20% | 478,862 | 587.24M |
| 449 | AGMB | AgomAb Therapeutics NV | 659.92M | -2.55% | 58,421 | - |
| 450 | CRMD | CorMedix Inc. | 659.80M | -0.65% | 433,981 | 462.25M |
| 451 | AUTL | Autolus Therapeutics plc | 654.76M | -3.15% | 1,435,958 | 117.39M |
| 452 | ANGO | AngioDynamics, Inc. | 653.05M | -1.68% | 56,138 | 320.17M |
| 453 | VALN | Valneva SE | 641.15M | 0.57% | 20,703 | 163.30M |
| 454 | SGMT | Sagimet Biosciences Inc. | 638.37M | -2.93% | 511,919 | - |
| 455 | OABI | OmniAb, Inc. | 638.26M | 4.77% | 1,571,735 | 38.46M |
| 456 | MDXG | MiMedx Group, Inc. | 634.79M | -2.13% | 633,830 | 355.17M |
| 457 | TLRY | Tilray Brands, Inc. | 619.76M | -5.38% | 1,991,374 | 915.45M |
| 458 | CTKB | Cytek Biosciences, Inc. | 616.12M | 0.85% | 272,761 | 206.71M |
| 459 | VSTM | Verastem, Inc. | 612.21M | -7.33% | 1,066,191 | 87.53M |
| 460 | BWAY | BrainsWay Ltd. | 604.84M | -0.89% | 26,325 | 60.70M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 596.67M | -1.00% | 105,317 | - |
| 462 | ARVN | Arvinas, Inc. | 592.73M | -6.35% | 202,705 | 316.70M |
| 463 | EIKN | Eikon Therapeutics, Inc. | 592.51M | -8.92% | 277,018 | - |
| 464 | PRME | Prime Medicine, Inc. | 589.75M | -6.36% | 2,161,159 | 4.07M |
| 465 | CTEV | Claritev Corporation | 586.64M | -2.19% | 34,049 | 994.67M |
| 466 | WEAV | Weave Communications, Inc. | 584.79M | - | 1,840,416 | 257.79M |
| 467 | DCTH | Delcath Systems, Inc. | 578.78M | -2.74% | 132,897 | 95.42M |
| 468 | ALT | Altimmune, Inc. | 574.80M | -5.29% | 2,509,455 | 31.00K |
| 469 | SPRY | ARS Pharmaceuticals, Inc. | 573.81M | -9.56% | 921,070 | 116.93M |
| 470 | CERS | Cerus Corporation | 568.30M | -1.05% | 1,157,110 | 221.55M |
| 471 | ENTX | Entera Bio Ltd. | 557.52M | 3.54% | 279,099 | 42.00K |
| 472 | AQST | Aquestive Therapeutics, Inc. | 557.27M | -3.27% | 1,107,033 | 54.09M |
| 473 | EOLS | Evolus, Inc. | 553.50M | -2.56% | 216,120 | 316.49M |
| 474 | FLGT | Fulgent Genetics, Inc. | 551.41M | 1.52% | 86,540 | 323.93M |
| 475 | ZURA | Zura Bio Limited | 545.27M | -2.57% | 247,036 | - |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 541.21M | -5.38% | 149,827 | 251.00K |
| 477 | OVID | Ovid Therapeutics Inc. | 536.09M | -6.31% | 454,052 | 1.58M |
| 478 | CABA | Cabaletta Bio, Inc. | 531.52M | 1.13% | 2,731,997 | - |
| 479 | TCMD | Tactile Systems Technology, Inc. | 527.12M | -1.40% | 72,245 | 350.31M |
| 480 | SRTA | Strata Critical Medical, Inc. | 523.72M | 0.51% | 221,266 | 255.98M |
| 481 | MPLT | MapLight Therapeutics, Inc. | 521.75M | -7.41% | 154,307 | - |
| 482 | EVH | Evolent Health, Inc. | 515.55M | -0.44% | 836,282 | 2.10B |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 507.12M | -7.55% | 432,269 | - |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 485 | DNA | Ginkgo Bioworks Holdings, Inc. | 496.30M | -4.41% | 664,902 | 132.42M |
| 486 | BLSM | BlossomHill Therapeutics, Inc. | 491.52M | -0.80% | 94,572 | - |
| 487 | EDIT | Editas Medicine, Inc. | 490.69M | -1.69% | 1,055,579 | 47.01M |
| 488 | RLMD | Relmada Therapeutics, Inc. | 490.15M | -4.87% | 481,247 | - |
| 489 | RZLT | Rezolute, Inc. | 489.43M | -0.74% | 448,746 | - |
| 490 | EVMN | Evommune, Inc. | 487.40M | -10.53% | 377,282 | 10.00M |
| 491 | CCCC | C4 Therapeutics, Inc. | 485.95M | -6.18% | 1,177,358 | 35.04M |
| 492 | NPCE | NeuroPace, Inc. | 476.42M | -5.19% | 53,554 | 106.99M |
| 493 | SENS | Senseonics Holdings, Inc. | 476.40M | -1.10% | 265,594 | 48.55M |
| 494 | PBYI | Puma Biotechnology, Inc. | 475.42M | -2.95% | 72,209 | 231.24M |
| 495 | CLPT | ClearPoint Neuro, Inc. | 475.26M | -2.38% | 177,374 | 42.28M |
| 496 | NRC | NRC Health | 474.46M | -2.41% | 40,737 | 140.00M |
| 497 | OCGN | Ocugen, Inc. | 473.06M | -5.74% | 2,396,414 | 4.58M |
| 498 | QTTB | Q32 Bio Inc. | 472.74M | 0.25% | 208,331 | 53.74M |
| 499 | EYPT | EyePoint, Inc. | 469.86M | -13.49% | 4,166,954 | 2.79M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.56M | -2.43% | 60,790 | - |